{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:42:06Z","timestamp":1783464126851,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ogc.2022.10.003","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:04:19Z","timestamp":1677017059000},"page":"89-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection"],"prefix":"10.1016","volume":"50","author":[{"given":"Kathleen F.","family":"Brookfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osinakachukwu","family":"Mbata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000433994.46087.85","article-title":"Committee Opinion No. 573: magnesium sulfate use in obstetrics","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.ogc.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Australasian Collaborative Trial of Magnesium Sulphate Collaborative G. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"Crowther","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-0528.2006.01162.x","article-title":"Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial","volume":"114","author":"Marret","year":"2007","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.ogc.2022.10.003_bib4","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A\u00a0randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"Rouse","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib5","first-page":"131","article-title":"The use of the magnesium ion in the management of eclamptogenic toxemias","volume":"100","author":"Pritchard","year":"1955","journal-title":"Surg Gynecol Obstet"},{"issue":"14","key":"10.1016\/j.ogc.2022.10.003_bib6","article-title":"Magnesium Sulfate-Mediated Vascular Relaxation and Calcium Channel Activity in Placental Vessels Different From Nonplacental Vessels","volume":"7","author":"Tang","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib7","first-page":"261","article-title":"Effect of magnesium sulfate on electroencephalographic findings in preeclampsia-eclampsia","volume":"64","author":"Sibai","year":"1984","journal-title":"Obstet Gynecol"},{"issue":"13","key":"10.1016\/j.ogc.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2165\/00003088-200241130-00007","article-title":"Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women","volume":"41","author":"Lu","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.003_bib9","doi-asserted-by":"crossref","first-page":"737 e1-e9","DOI":"10.1016\/j.ajog.2015.12.060","article-title":"Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women","volume":"214","author":"Brookfield","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1067\/mob.2001.116726","article-title":"Population pharmacokinetics of magnesium in preeclampsia","volume":"185","author":"Chuan","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ogc.2022.10.003_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/1471-0528.12222","article-title":"Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study","volume":"120","author":"Salinger","year":"2013","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jcph.1328","article-title":"Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia","volume":"59","author":"Du","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40268-020-00315-2","article-title":"Population pharmacokinetics of magnesium sulfate in preeclampsia and associated factors","volume":"20","author":"da Costa","year":"2020","journal-title":"Drugs R D"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.003_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcph.941","article-title":"Optimization of maternal magnesium sulfate administration for fetal neuroprotection: application of a prospectively constructed pharmacokinetic model to the BEAM cohort","volume":"57","author":"Brookfield","year":"2017","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.003_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/jcph.1448","article-title":"Alternative magnesium sulfate dosing regimens for women with preeclampsia: a population pharmacokinetic exposure-response modeling and simulation study","volume":"59","author":"Du","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ogc.2022.10.003_bib16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/1471-0528.13753","article-title":"Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia","volume":"123","author":"Okusanya","year":"2016","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0039-6109(16)35131-3","article-title":"Plasma levels of magnesium attained in magnesium sulfate therapy for preeclampsia and eclampsia","volume":"37","author":"Chesley","year":"1957","journal-title":"Surg Clin North Am"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib18","first-page":"199","article-title":"Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia","volume":"57","author":"Sibai","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2022.10.003_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2393-13-34","article-title":"An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management","volume":"13","author":"Smith","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0884217504263145","article-title":"Deep tendon reflexes, magnesium, and calcium: assessments and implications","volume":"33","author":"Nick","year":"2004","journal-title":"J\u00a0Obstet Gynecol Neonatal Nurs"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.003_bib21","first-page":"CD000025","article-title":"Magnesium sulphate and other anticonvulsants for women with pre-eclampsia","volume":"10","author":"Duley","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"9321","key":"10.1016\/j.ogc.2022.10.003_bib22","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.003_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/00003088-200038040-00002","article-title":"Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles","volume":"38","author":"Lu","year":"2000","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.003_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/0002-9378(84)90676-8","article-title":"A\u00a0comparison of intravenous and intramuscular magnesium sulfate regimens in preeclampsia","volume":"150","author":"Sibai","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.003_bib25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/10641950902928704","article-title":"Zuspan's scheme versus an alternative magnesium sulfate scheme: Randomized clinical trial of magnesium serum concentrations","volume":"29","author":"Abbade","year":"2010","journal-title":"Hypertens Pregnancy"},{"issue":"5","key":"10.1016\/j.ogc.2022.10.003_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/14767050903156684","article-title":"The effect of magnesium sulfate treatment on blood biochemistry and bleeding time in patients with severe preeclampsia","volume":"23","author":"Guzin","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.003_bib27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ogc.2022.10.003_bib28","first-page":"481095","article-title":"Public health perspectives of preeclampsia in developing countries: implication for health system strengthening","volume":"2011","author":"Osungbade","year":"2011","journal-title":"J\u00a0Pregnancy"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/aogs.12807","article-title":"Alternative regimens of magnesium sulfate for treatment of preeclampsia and eclampsia: a systematic review of non-randomized studies","volume":"95","author":"Pratt","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.ogc.2022.10.003_bib30","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.xagr.2021.100018","article-title":"Magnesium sulfate pharmacokinetics after intramuscular dosing in women with preeclampsia","volume":"1","author":"Brookfield","year":"2021","journal-title":"AJOG Glob Rep"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.003_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ijgo.13195","article-title":"Global burden of preterm birth","volume":"150","author":"Walani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib32","first-page":"CD009302","article-title":"Different magnesium sulphate regimens for neuroprotection of the fetus for women at risk of preterm birth","volume":"15","author":"Bain","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ogc.2022.10.003_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/GCO.0000000000000529","article-title":"Magnesium sulfate use for fetal neuroprotection","volume":"31","author":"Brookfield","year":"2019","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2022.10.003_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000484891","article-title":"Magnesium as a neuroprotective agent: a review of its use in the fetus, term infant with neonatal encephalopathy, and the adult stroke patient","volume":"40","author":"Lingam","year":"2018","journal-title":"Dev Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.ogc.2022.10.003_bib35","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ndtplus\/sfr163","article-title":"Magnesium basics","volume":"5","author":"Jahnen-Dechent","year":"2012","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.ogc.2022.10.003_bib36","doi-asserted-by":"crossref","first-page":"e1174","DOI":"10.1016\/S2214-109X(17)30420-5","article-title":"Making sense of cerebral palsy prevalence in low-income countries","volume":"5","author":"Dan","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.ogc.2022.10.003_bib37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/dmcn.14926","article-title":"Epidemiology of cerebral palsy in low- and middle-income countries: preliminary findings from an international multi-centre cerebral palsy register","volume":"63","author":"Jahan","year":"2021","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"10.1016\/j.ogc.2022.10.003_bib38","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/AOG.0000000000004137","article-title":"Alternate dosing protocol for magnesium sulfate in obese women with preeclampsia: a randomized controlled trial","volume":"136","author":"Brookfield","year":"2020","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854522000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:25:54Z","timestamp":1760178354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854522000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0889854522000948"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.003","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium Sulfate Use in Pregnancy for Preeclampsia Prophylaxis and Fetal Neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}